Key research themes
1. How do antimicrobial peptides mechanistically combat bacterial biofilms and what implications does this have for overcoming multidrug resistance?
This area focuses on the specific biochemical and biophysical mechanisms by which antimicrobial peptides (AMPs) inhibit biofilm formation, disrupt mature biofilms, and kill biofilm-embedded bacteria. Understanding these mechanisms is critical because biofilms confer enhanced tolerance and resistance to conventional antibiotics, making infections difficult to eradicate. Characterizing AMP antibiofilm activity also facilitates the rational design of peptides to target hard-to-treat multidrug-resistant pathogens in both planktonic and biofilm states.
2. What are the molecular mechanisms and immunomodulatory roles of antimicrobial peptides beyond direct microbial killing?
This theme explores the multifunctional nature of AMPs, including their direct antibacterial and antibiofilm activities, in addition to their roles in modulating host immune responses and inflammation. Investigation into mechanisms such as membrane permeabilization, intracellular targeting, immune recruitment and regulation, and synergy with antibiotics is vital to optimizing AMPs as therapeutic agents for both extracellular and intracellular infections, and to limit resistance evolution.
3. How can antimicrobial peptides be designed, evaluated, and leveraged to address antibiotic resistance in clinically relevant multidrug-resistant pathogens?
This theme centers on the translational aspects of AMP research, including databases, computational design tools, preclinical evaluation methods, and clinical considerations. It addresses how AMP structural features correlate with activity and toxicity, strategies to enhance stability and specificity, and their synergistic use with existing antibiotics. Research in this domain drives AMP optimization and paves the way for new antimicrobial drugs targeting WHO priority multidrug-resistant bacteria.